Changes in B-type natriuretic peptides after surgical ventricular restoration

Area of Science:

• Cardiology
• Cardiac Surgery
• Heart Failure Research

Background:

• Post-infarction left ventricular remodeling leads to heart failure.
• Surgical Ventricular Restoration (SVR) is a potential treatment for this condition.
• Changes in natriuretic peptides (BNP and NT-pro-BNP) may reflect treatment efficacy.

Purpose of the Study:

• To prospectively evaluate changes in brain natriuretic peptide (BNP) and amino terminal pro-BNP (NT-pro-BNP) after Surgical Ventricular Restoration (SVR).
• To assess the relationship between natriuretic peptide levels and functional status post-SVR.
• To investigate the long-term impact of SVR on cardiac function and peptide levels.

Main Methods:

• Prospective study of 29 patients with post-infarction left ventricular aneurysm and reduced ejection fraction undergoing SVR (Dor technique).
• Measurements of natriuretic peptides, functional status (NYHA class), ejection fraction, and ventricular volumes at baseline, 6 months, and late follow-up.
• Statistical analysis to correlate changes in peptide levels with functional and volumetric improvements.

Main Results:

• SVR showed 93% survival at 24 months with significant improvement in NYHA class (86% in class I/II at 6 months, all at late follow-up).
• Significant reduction in NT-pro-BNP and BNP levels observed at 6 months and late follow-up.
• Ejection fraction improved significantly (24% to 37%), and left ventricular volumes decreased.
• Functional improvement correlated significantly with reductions in BNP and NT-pro-BNP.

Conclusions:

• Surgical Ventricular Restoration (SVR) effectively reverses heart failure secondary to post-infarction left ventricular remodeling.
• Reduced B-type natriuretic peptide levels at 6 months post-surgery are associated with clinical improvement.
• SVR leads to sustained clinical benefit and further peptide level reduction at late follow-up.